Showing results (71-80 of 261) with videos related to

Sort By:
Pageof 27
Blood|July 20, 2002
Development of a murine hematopoietic progenitor complementary DNA microarray using a subtracted complementary DNA libraryXianyong Ma, Tupur Husain, Hui Peng, et al.
Cell Reports|August 18, 2021
Mds1CreERT2, an inducible Cre allele specific to adult-repopulating hematopoietic stem cellsYi Zhang, Kathleen E McGrath, Edward Ayoub, et al.
Cancer|September 6, 2013
Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare StudyPeter Martin, Michelle Byrtek, Keith Dawson, et al.
Leukemia Research|October 26, 2005
Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experienceRoberto L Vargas, Enzo Fallone, Raymond E Felgar, et al.
British Journal of Haematology|February 25, 2020
First-line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)-Medicare population-based studyAngie Mae Rodday, Theresa Hahn, Anita J Kumar, et al.
JAMA Network Open|October 21, 2021
Association of Treatment Intensity With Survival in Older Patients With Hodgkin LymphomaAngie Mae Rodday, Theresa Hahn, Anita J Kumar, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 10, 2023
Healthcare Utilization Disparities of Adolescent and Young Adults Compared to the Older Lymphoma PopulationKriti Thapa, Myla Strawderman, Patrick M Reagan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 10, 2004
cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer modelHarriet M Kluger, Yuval Kluger, Maureen Gilmore-Hebert, et al.
British Journal of Haematology|June 19, 2015
Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cellsAndrew G Evans, Paul G Rothberg, W Richard Burack, et al.
Leukemia & Lymphoma|August 27, 2016
[18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practiceIda Wong-Sefidan, Michelle Byrtek, Xiaolei Zhou, et al.
Pageof 27